Join us virtually for a unique educational experience. In this debate-style series, nationally recognized thought leaders take opposing sides on clinical, and sometimes controversial, topics currently disrupting the practice of hematology/oncology.
Through a comprehensive review of the latest clinical advancements in hematologic malignancies, robust audience engagement, and ample discussion, participants will leave equipped with practical implications and applications to put into practice immediately.
New Exclusive Session for 2021: Interdisciplinary Management of Adverse Events
Insider Scoop: What Should Practicing Hematologists/Oncologists Know About Cardiotoxicity
Approach to Immunotherapy- and Other Targeted Therapy-Related Toxicities
Management Approaches with Antibodies and CAR-T Cells
Physician, PhD, PharmD: USD 279.00,
Nurse Practitioner, Physician Assistant: USD 169.00,
Nurse, Student, Resident, Fellow: USD 89.00,
Pharmaceutical Industry: USD 549.00
Time: 09:00 to 16:15